Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$19.54 - $28.66 $40,369 - $59,211
-2,066 Reduced 1.15%
178,130 $4.87 Million
Q3 2023

Nov 16, 2023

SELL
$21.15 - $27.96 $1.36 Million - $1.8 Million
-64,421 Reduced 26.34%
180,196 $4.89 Million
Q2 2023

Aug 14, 2023

SELL
$11.16 - $23.65 $233,668 - $495,183
-20,938 Reduced 7.88%
244,617 $5.52 Million
Q1 2023

May 15, 2023

BUY
$10.12 - $14.91 $2.69 Million - $3.96 Million
265,555 New
265,555 $2.99 Million

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $436M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.